Paper Details

  1. Home
  2. Paper Details

Cost Effectiveness of Chemotherapeutic Agents and Targeted Biologics in Ovarian Cancer: A Systematic Review.

Author: DuXianglin L, LairsonDavid R, ParikhRohan C, PoonawallaInsiya B, VonVilleHelena M

Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Chemotherapy is a common treatment for advanced ovarian cancer when surgery alone isn't enough. While the cancer often returns, newer targeted medications can sometimes improve survival and quality of life, but they are very expensive. More research is needed to understand the cost-effectiveness of these new treatments.
Paper Details　
Original Abstract of the Article :
Adjuvant chemotherapy is a key component of advanced ovarian cancer treatment, when surgery alone is not sufficient. Recurrence is common in ovarian cancer patients and most women require prolonged second-line and higher-line chemotherapy. With newer targeted therapies, modest improvements in surviv...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s40273-015-0304-9

データ提供：米国国立医学図書館（NLM）

Navigating the Shifting Sands of Ovarian Cancer Treatment: Cost-Effectiveness of Chemotherapy and Targeted Therapies

Ovarian cancer, a complex and challenging disease, often requires a multi-faceted approach to treatment, much like navigating a treacherous desert landscape. This study, like a financial analyst evaluating investment opportunities, examines the cost-effectiveness of different chemotherapeutic agents and targeted biologics in treating ovarian cancer. The authors conducted a systematic review, evaluating the economic efficiency of various treatments and their impact on survival and quality of life.

Cost-Effectiveness: Finding the Right Balance

The study highlights the need for a balanced approach to ovarian cancer treatment, considering both clinical efficacy and economic factors. While newer targeted therapies may offer modest improvements in survival and quality of life, their high cost necessitates careful evaluation of their cost-effectiveness. The authors emphasize the importance of assessing the value of different treatments and finding the most efficient strategies for managing ovarian cancer.

Optimizing Ovarian Cancer Treatment: A Multifaceted Approach

This study emphasizes the need for a multidisciplinary approach to ovarian cancer management, considering the unique needs and preferences of each patient. Balancing cost-effectiveness with clinical effectiveness is crucial in finding the best treatment options. Continued research into cost-effective therapies and personalized treatment strategies is essential for improving outcomes and enhancing the quality of life for individuals living with ovarian cancer.

Dr. Camel's Conclusion

The cost-effectiveness of different chemotherapeutic agents and targeted biologics in treating ovarian cancer needs to be carefully considered, balancing clinical efficacy with economic factors.

Date :
  1. Date Completed 2016-12-13
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26072142

DOI: Digital Object Identifier

10.1007/s40273-015-0304-9

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.